Document is current
Any future updates will be listed below
-
Authors
Allen, Victoria B.
Bechman, Katie
Russell, Mark D.
Adas, Maryam A.
Goodman, Anna L.
McPhail, Mark J.
Norton, Sam
Galloway, James B.
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR303293)
- License Information
-
More Information
Article History
Received: 24 April 2025
Accepted: 1 July 2025
First Online: 15 July 2025
Declarations
:
: VBA, MAA, AG, MJM and SN have no known competing financial interests. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JBG has received honoraria from Abbvie, Amgen, Celgene, Chugai, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Roche, Sobi, and UCB, and has research funding from Amgen, Aztra-Zeneca, Gilead, Janssen, Medicago, Novovax and Pfizer. MDR has received honoraria from AbbVie, Biogen, Lilly, Galapagos, Menarini, UCB, and Viforpharma. KB has received grant funding from the Pfizer/Versus Arthritis; honoraria from Galapagos, UCB, and Viforpharma; and educational support from UCB.
